Lmr Partners LLP Insmed Inc Call Options Transaction History

Lmr Partners LLP

  • $10.9 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 07, 2024
SELL
$62.0 - $79.01 $2.02 Million - $2.58 Million
-32,600 Reduced 43.94%
41,600 $3.04 Million
Q2 2024

Aug 14, 2024
SELL
$22.0 - $69.71 $796,400 - $2.52 Million
-36,200 Reduced 32.79%
74,200 $4.97 Million
Q1 2024

May 15, 2024
BUY
$25.72 - $29.94 $1.81 Million - $2.11 Million
70,400 Added 176.0%
110,400 $3 Million
Q4 2023

Feb 14, 2024
BUY
$23.42 - $31.74 $936,800 - $1.27 Million
40,000 New
40,000 $1.24 Million

Others Institutions Holding INSM

# of Institutions
467
Shares Held
182M
Call Options Held
2.27M
Put Options Held
3.33M
View Full List

About INSMED Inc

INSM Quotes by TradingView
  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $10B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Lmr Partners LLP Portfolio

Follow Lmr Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Lmr Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email